—
Global Antifungal Drugs Market 2019-2023:A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Antifungal Drugs Market. The report analyses the Antifungal Drugs Market By Drug Type (Azoles, Echinocandins, Polyenes, Others), By Therapeutic Indications (Candidiasis, Aspergillosis, Dermatophytosis, Others). The report analyses the Antifungal Drugs Market, By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada, Germany, U.K, France, China, Japan, India) for the historical period of 2013-2017 and the forecast period of 2018-2023.
According to Publisher’s research report Global Antifungal Drugs Market is projected to display a robust growth represented by a CAGR of 3.70% during 2018 – 2023.
Over the recent years, Antifungal Drugs market has been witnessing growth on account of several driving factors including growing prevalence of fungal infections such as candidiasis and aspergillosis, increasing popularity of over-the-counter drugs, and increase in availability of innovative antifungals. Moreover, increasing awareness regarding fatal antifungal diseases, growing medical spending, favorable government initiatives, public private partnership have been driving the market growth. In addition, rising geriatric population, increasing global healthcare expenditure and technological advancements in pharmaceuticals research, growing scope in developing countries with large population such as China and India is anticipated to impel the market growth of the antifungal drugs market. However, growing portfolio of antifungal generic drugs, patent expiration of innovator drugs, increasing prevalence of fungal resistance, and counterfeit drugs are expected to hinder the market performance during forecasted period.
Get Sample Copy of this Report@ https://www.orbisresearch.com/contacts/request-sample/2646976
Scope of the Report:
Global Antifungal Drugs Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)
Antifungal Drugs Market– Size, Growth, Forecast
Analysis By Drug Type - Azole Class Antifungal Drugs, Echinocandins Class Antifungal Drugs, Polyenes Class Antifungal Drugs, Other Class Antifungal Drugs
Analysis By Therapeutic Indications - Aspergillus, Dermatophytosis, Candidiasis, Other Therapeutic Indications
Regional Antifungal Drugs Market – North America, Europe, Asia Pacific, Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
Antifungal Drugs Market– Size, Growth, Forecast
Analysis By Drug Type - Azole Class Antifungal Drugs, Echinocandins Class Antifungal Drugs, Polyenes Class Antifungal Drugs, Other Class Antifungal Drugs
Analysis By Therapeutic Indications - Aspergillus, Dermatophytosis, Candidiasis, Other Therapeutic Indications
Country Analysis – U.S., Canada, Germany, U.K, France, China, Japan, India (Actual Period: 2013-2017, Forecast Period: 2018-2023)
Antifungal Drugs Market– Size, Growth, Forecast
Analysis By Drug Type - Azole Class Antifungal Drugs, Echinocandins Class Antifungal Drugs, Polyenes Class Antifungal Drugs, Other Class Antifungal Drugs
Analysis By Therapeutic Indications - Aspergillus, Dermatophytosis, Candidiasis, Other Therapeutic Indications
Other Report Highlights
Market Dynamics – Drivers and Restraints.
Market Trends.
Porter Five Forces Analysis.
SWOT Analysis.
Company Analysis - Merck & Co., Glaxo Smith Kline, Astellas Pharma, Sanofi, Abbott Laboratories, Bayer, Kramer Laboratories, Novartis International AG, Pfizer.
Customization of the Report
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
Make an Inquiry before Buying this Report@ https://www.orbisresearch.com/contacts/enquiry-before-buying/2646976
In this research report, the market is segmented on the basis of drug class and therapeutic indications. By drug class, the azoles class antifungals are predicted to hold their dominant position in the market. By therapeutic indications, drugs use in the treatment of candidiasis are anticipated to creates their dominance in global antifungal drugs market. Amongst the regions, North America accounts for the largest regional share in the global antifungal drugs market in 2017. The largest share of North America is attributed to presence of enormous number of patient base and highly advanced medical infrastructure.
The report titled “Global Antifungal Drugs Market: Analysis By Drug Class (Azoles, Echinocandins, Polyenes, Others), By Therapeutic Indications (Candidiasis, Aspergillosis, Dermatophytosis, Others), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, Asia Pacific, ROW), By Country (U.S., Canada, Germany, U.K, France, China, Japan, India)”, has covered and analysed the potential of antifungal drugs market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the antifungal drugs. Additionally, the report also highlights market entry strategies for various companies across the globe.
Complete Report on “Global Antifungal Drugs Market” Spread across 240 Pages, List of Tables & Figures and In-depth Table of Contents is now available@ https://www.orbisresearch.com/contact/purchase/2646976
Key Points from TOC:
1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Antifungal Drugs Products Outlook
5. Global Antifungal Drugs Market: Growth and Forecast
6. Global Antifungal Drugs Market: Segmental Analysis
6.1 Global Antifungal Drugs Market Size, By Drug Class: Breakdown (%)
6.1.1 Global Antifungal Drugs Market Size, By Drug Class, 2017 (%)
6.1.2 Global Antifungal Drugs Market Size, By Drug Class, 2023 (%)
6.2 Global Azole Class Antifungal Drugs Market Size, By Value (2013-2023)
6.3 Global Echinocandins Class Antifungal Drugs Market Size, By Value (2013-2023)
6.4 Global Polyenes Antifungal Drugs Market Size, By Value (2013-2023)
6.5 Global Other Antifungal Drugs Market Size, By Value (2013-2023)
6.6 Global Antifungal Drugs: Market Attractiveness, By Drug Class
6.7 Global Antifungal Drugs Market Size, By Therapeutic Indications : Breakdown(%)
6.7.1 Global Aspergillus Antifungal Drugs Market Size, By Value (2013-2023)
6.7.2 Global Dermatophytosis Antifungal Drugs Market Size, By Value (2013-2023)
6.7.3 Global Candidiasis Antifungal Drugs Market Size, By Value (2013-2023)
6.6.2 Global Other Therapeutic Indications Antifungal Drugs Market Size, By Value (2013-2023)
7. Global Antifungal Drugs Market: Regional Analysis
8. North America Antifungal Drugs Market: An Analysis
9. Europe Antifungal Drugs Market: An Analysis
10. APAC Antifungal Drugs Market: An Analysis
11. ROW Antifungal Drugs Market: Growth and Forecast
12. Global Antifungal Drugs Market: Market Dynamics
13. Porter Five Force Analysis
14. SWOT Analysis
15. Antifungal Drugs Market – Competitive Landscape
16. Company Profiles
16.1 Merck & Co.
16.2 Pfizer
16.3 GSK
16.4 Novartis
16.5 Abbott Laboratories
16.6 Astellas Pharma
16.7 Bayer
16.8 Sanofi
16.9 Kramer Laboratories
Get More Information about this Report@ https://www.orbisresearch.com/reports/index/global-antifungal-drugs-market-analysis-by-drug-class-by-therapeutic-indications-by-region-by-country-2019-edition-opportunities-and-forecast-2013-2023-by-region-by-country
(Note: If you have any special requirements, please let us know and we will offer you the report as you want.)
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Info:
Name: Hector Costello
Email: Send Email
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A.
Phone: +1 (214) 884-6817
Website: http://www.orbisresearch.com
Release ID: 482132
Google
RSS